Tazobactam: Difference between revisions
m Protected "Tazobactam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 21: | Line 21: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Tazobactam''' is a compound which inhibits the action of bacterial [[beta-lactamase]]s. It is added to the [[Beta-lactam antibiotic|extended spectrum beta-lactam]] [[antibiotic]] [[piperacillin]] to produce Tazocin® or Zosyn®. It broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin. | '''Tazobactam''' is a compound which inhibits the action of bacterial [[beta-lactamase]]s. It is added to the [[Beta-lactam antibiotic|extended spectrum beta-lactam]] [[antibiotic]] [[piperacillin]] to produce Tazocin® or Zosyn®. It broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin. | ||
| Line 32: | Line 32: | ||
{{PenicillinAntiBiotics}} | {{PenicillinAntiBiotics}} | ||
[[Category:Beta-lactamase inhibitors]] | [[Category:Beta-lactamase inhibitors]] | ||
[[th:ทาโซแบคแตม]] | [[th:ทาโซแบคแตม]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:41, 20 August 2012
| File:Tazobactam structure.svg | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H12N4O5S |
| Molar mass | 300.289 g/mol |
|
WikiDoc Resources for Tazobactam |
|
Articles |
|---|
|
Most recent articles on Tazobactam |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tazobactam at Clinical Trials.gov Clinical Trials on Tazobactam at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tazobactam
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tazobactam Discussion groups on Tazobactam Patient Handouts on Tazobactam Directions to Hospitals Treating Tazobactam Risk calculators and risk factors for Tazobactam
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tazobactam |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Tazobactam is a compound which inhibits the action of bacterial beta-lactamases. It is added to the extended spectrum beta-lactam antibiotic piperacillin to produce Tazocin® or Zosyn®. It broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin.
Tazobactam sodium is a derivative of the penicillin nucleus and is a penicillanic acid sulfone.
External links
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta-lactamase inhibitors